Document is current

Article History

Received: 26 March 2025

Accepted: 14 July 2025

First Online: 27 July 2025

Declarations

:

: PAM has received honoraria for advisory role from Sanofi and Sun Pharma and speaking grants and travel/accommodation expenses from MSD, Pierre-Fabre and Novartis. MABG has received honoraria for consulting fees, lectures, speaker bureaus, manuscript writing and educational events from BMS, MSD, Novartis, Pierre Fabre and Regeneron. CAR has received honoraria for consulting fees, lectures, speaker bureaus, manuscript writing and educational events from Takeda, MSD, Roche, Pierre Fabre, Regeneron, Astra Zeneca, Amge and Pfizer, travel/accommodation expenses from Pierre Fabre and MSD and research funding from Astra Zeneca, BMS, Mirati, MSD and Amgen. PCF has received consulting fees from Pierre Fabre, honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from BMS, MSD, Novartis and Pierre Fabre and travel/accommodation expenses from MSD, Novartis and Pierre Fabre. BCB has received fees, honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from BMS, MSD, Novartis, Pierre Fabre, Roche and Regeneron and travel/accommodation expenses from MSD, Novartis and Pierre Fabre. IMR has received honoraria for advisory role from Amgen, Astra Zeneca, BiolineRx, BMS, Celegene, GSK, Highlight Therapeutics, Immunocore, Merck Serono, MSD, Novartis, Pierre Fabre, Regeneron, Roche, Sanofi and Sun Pharma and travel/accommodation expenses from Amgen, BMS, GSK, Highlight Therapeutics, MSD, Novartis, Pierre Fabre, Roche and Sun Pharma. The remaining co-authors have no conflicts of interest to declare regarding this paper.

: The study was approved by the Ethics investigational committee of Hospital Universitario Gregorio Marañón (Reference: 06/2018).

: All patients provided written informed consent for study participation.